{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:07:03Z","timestamp":1792843623829,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-024-03273-6","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:02:56Z","timestamp":1726495376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice"],"prefix":"10.1186","volume":"24","author":[{"given":"Tongtong","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"4","key":"3273_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00281-016-0560-6","volume":"38","author":"CT Robb","year":"2016","unstructured":"Robb CT, Regan KH, Dorward DA, et al. Key mechanisms governing resolution of lung inflammation. Seminars in Immunopathology. 2016;38(4):425\u201348.","journal-title":"Seminars in Immunopathology"},{"issue":"5","key":"3273_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/tox.23479","volume":"37","author":"RE Go","year":"2022","unstructured":"Go RE, Lee SM, Shin YJ, et al. Time-dependent effect of inhaled cigarette smoke exposure in the bleomycin-induced lung injury rat model. Environ Toxicol. 2022;37(5):1231\u201343.","journal-title":"Environ Toxicol"},{"key":"3273_CR3","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa050333","volume":"353","author":"D Gordon","year":"2005","unstructured":"Gordon D, Rubenfeld MD, Caldwell E, et al. Incidence and outcomes of acute lung injury. New England J Med. 2005;353:1685\u201393.","journal-title":"New England J Med"},{"issue":"6","key":"3273_CR4","doi-asserted-by":"publisher","first-page":"1901105","DOI":"10.1183\/13993003.01105-2019","volume":"55","author":"P Kolb","year":"2020","unstructured":"Kolb P, Upagupta C, Vierhout M, et al. The importance of interventional timing in the bleomycin model of pulmonary fibrosis. Eur Respir J. 2020;55(6):1901105.","journal-title":"Eur Respir J"},{"issue":"5","key":"3273_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1753465809348014","volume":"3","author":"MM del Giudice","year":"2009","unstructured":"del Giudice MM, Pezzulo A, Capristo C, et al. Leukotriene modifiers in the treatment of asthma in children. Ther Adv Respir Dis. 2009;3(5):245\u201351.","journal-title":"Ther Adv Respir Dis"},{"issue":"12","key":"3273_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/17476348.2019.1670640","volume":"13","author":"HKT Trinh","year":"2019","unstructured":"Trinh HKT, Lee S-H, Cao TBT, et al. Asthma pharmacotherapy: an update on leukotriene treatments. Expert Rev Respir Med. 2019;13(12):1169\u201378.","journal-title":"Expert Rev Respir Med"},{"issue":"7","key":"3273_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.5858\/arpa.2016-0342-RA","volume":"141","author":"KT Hughes","year":"2017","unstructured":"Hughes KT, Beasley MB. Pulmonary manifestations of acute lung injury: more than just diffuse alveolar damage. Arch Pathol Lab Med. 2017;141(7):916\u201322.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"3273_CR8","doi-asserted-by":"publisher","first-page":"e20230085","DOI":"10.36416\/1806-3756\/e20230085","volume":"49","author":"A Franco Amaral","year":"2023","unstructured":"Franco Amaral A, De Figueiredo Braga Colares P, Adib Kairalla R. Idiopathic pulmonary fibrosis: current diagnosis and treatment. J Br Pneumol. 2023;49(4):e20230085.","journal-title":"J Br Pneumol"},{"key":"3273_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/608930","volume":"2014","author":"AJ Theron","year":"2014","unstructured":"Theron AJ, Steel HC, Tintinger GR, et al. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res. 2014;2014:1\u201316.","journal-title":"J Immunol Res"},{"issue":"5","key":"3273_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","volume":"56","author":"RG Jenkins","year":"2017","unstructured":"Jenkins RG, Moore BB, Chambers RC, et al. An official american thoracic society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis. Am J Respir Cell Mol Biol. 2017;56(5):667\u201379.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"3273_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/diagnostics11050762","volume":"11","author":"E Baratella","year":"2021","unstructured":"Baratella E, Ruaro B, Giudici F, et al. Evaluation of correlations between genetic variants and high-resolution computed tomography patterns in idiopathic pulmonary fibrosis. Diagnostics. 2021;11(5):762.","journal-title":"Diagnostics"},{"key":"3273_CR12","doi-asserted-by":"publisher","first-page":"109482","DOI":"10.1016\/j.cellsig.2019.109482","volume":"66","author":"M Selman","year":"2020","unstructured":"Selman M, Pardo A. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis. Cell Signal. 2020;66:109482.","journal-title":"Cell Signal."},{"issue":"6","key":"3273_CR13","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1172\/JCI45961","volume":"121","author":"MF Beers","year":"2011","unstructured":"Beers MF, Morrisey EE. The three R\u2019s of lung health and disease: repair, remodeling, and regeneration. J Clin Investig. 2011;121(6):2065\u201373.","journal-title":"J Clin Investig"},{"key":"3273_CR14","first-page":"13","volume":"57","author":"H Yuksel","year":"2003","unstructured":"Yuksel H, Ozbilgin K, Coskun S, et al. 2003 protective effect of leukotriene receptor antagonist montelukast on smoking-induced lung injury in wistar rats. Acta Med Okayama. 2003;57:13\u20139.","journal-title":"Acta Med Okayama"},{"key":"3273_CR15","first-page":"1951","volume":"33","author":"J Seth","year":"2013","unstructured":"Seth J, Kligerman MD, Teri J, Franks MD, Jeffrey R, et al. Organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radio Pathol Arch. 2013;33:1951\u201375.","journal-title":"Radio Pathol Arch"},{"key":"3273_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.brainres.2015.08.007","volume":"1624","author":"L Chen","year":"2015","unstructured":"Chen L, Yang Y, Li C-T, et al. CysLT 2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro. Brain Res. 2015;1624:433\u201345.","journal-title":"Brain Res"},{"key":"3273_CR17","doi-asserted-by":"publisher","unstructured":"Nayak BK, Kumar A, Kothiyal P. Pharmacological evaluation of Zafirlukast in experimentally induced global cerebral ischemia\/reperfusion injury in mice. Int J Pharm Pharm Sci. 2018;10(2):30\u20136. https:\/\/doi.org\/10.22159\/ijpps.2018v10i2.21633.","DOI":"10.22159\/ijpps.2018v10i2.21633"},{"key":"3273_CR18","doi-asserted-by":"publisher","unstructured":"Jain NK, Kulkarni SK, Singh A. Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals. Eur J Pharmacol. 2001;423(1):85\u201392. https:\/\/doi.org\/10.1016\/S0014-2999(01)01083-4.","DOI":"10.1016\/S0014-2999(01)01083-4"},{"key":"3273_CR19","doi-asserted-by":"publisher","unstructured":"Gan W, Li X, Cui Y, Xiao T, Liu R, Wang M, Wei Y, Cui M, Ren S, Helian K, Ning W, Zhou H, Yang C. Pinocembrin relieves lipopolysaccharide and bleomycin induced lung inflammation via inhibiting TLR4-NF-\u03baBNLRP3 inflammasome signaling pathway. Int Immunopharmacol. 2021;90:107230. https:\/\/doi.org\/10.1016\/j.intimp.2020.107230.","DOI":"10.1016\/j.intimp.2020.107230"},{"key":"3273_CR20","unstructured":"Xiaohe Li, Ling Ma, Yuli Wei,et al. Cabozantinib ameliorates lipopolysaccharide-induced lung inflammation and bleomycin--induced early pulmonary fibrosis in mice[J]. International Immunopharmacology, 2021:1567\u20135769."},{"key":"3273_CR21","doi-asserted-by":"crossref","unstructured":"Davino-Chiovattoa JE, Oliveira-Junior MC, MacKenzie B. Montelukast, leukotriene inhibitor, reduces lps-induced acute lung inflammation and human neutrophil activation. 2019:0300\u20132896.","DOI":"10.1016\/j.arbres.2019.05.003"},{"issue":"1","key":"3273_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jmii.2016.04.005","volume":"51","author":"Y-C Lin","year":"2018","unstructured":"Lin Y-C, Huang M-Y, Lee M-S, et al. Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages. J Microbiol Immunol Infect. 2018;51(1):18\u201326.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"3273_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000121471","volume":"40","author":"HM Wang","year":"2008","unstructured":"Wang HM, Bodenstein M, Markstaller K. Overview of the Pathology of Three Widely Used Animal Models of Acute Lung Injury. Eur Surg Res. 2008;40(4):305\u201316.","journal-title":"Eur Surg Res"},{"key":"3273_CR24","doi-asserted-by":"publisher","unstructured":"Arezzini B, Vecchio D, Signorini C, Stringa B, Gardi C. F2-isoprostanes can mediate bleomycin-induced lung fibrosis. Free Radic Biol Med. 2018;115:1\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.11.007.","DOI":"10.1016\/j.freeradbiomed.2017.11.007"},{"key":"3273_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/MAJ.0b013e31821aa000","volume":"341","author":"AL Degryse","year":"2011","unstructured":"Degryse AL, Lawson WE. Progress toward improving animal models for idiopathic pulmonary fibrosis. Am J Med Sci. 2011;341:444\u20139.","journal-title":"Am J Med Sci"},{"key":"3273_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pupt.2018.07.002","volume":"51","author":"R Carrington","year":"2018","unstructured":"Carrington R, Jordan S, Pitchford SC, Page CP. Use of animal models in IPF research. Pulm Pharmacol Therapeu. 2018;51:73\u20138 ISSN 1094-5539.","journal-title":"Pulm Pharmacol Therapeu"},{"issue":"2","key":"3273_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/ejcts\/ezs312","volume":"43","author":"FG Al-Amran","year":"2013","unstructured":"Al-Amran FG, Hadi NR, Hashim AM. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats\u2020. Eur J Cardiothorac Surg. 2013;43(2):421\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"3273_CR28","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1080\/21655979.2021.2005895","volume":"12","author":"Z Guo","year":"2021","unstructured":"Guo Z, Zeng X, Zheng Y. Zafirlukast ameliorates Docetaxel-induced activation of NOD-like receptor protein 3 NLRP3 inflammasome mediated by sirtuin1 SIRT1 in hepatocytes. Bioengineered. 2021;12(2):11030\u201340.","journal-title":"Bioengineered"},{"key":"3273_CR29","unstructured":"Lu Chen, Yi Yang, Chen-Tan Li,et al. CysLT2 receptor mediates lipopolysaccharideinduced microglial inflammation and consequentneurotoxicity in vitro. 2015,08,007:0006\u20138993."},{"issue":"203","key":"3273_CR30","doi-asserted-by":"publisher","first-page":"112614","DOI":"10.1016\/j.ejmech.2020.112614","volume":"1","author":"X Li","year":"2020","unstructured":"Li X, Xie M, Lu C, Mao J, Cao Y, Yang Y, Wei Y, Liu X, Cao S, Song Y, Peng J, Zhou Y, Jiang Q, Lin G, Qin S, Qi M, Hou M, Liu X, Zhou H, Yang G, Yang C. Design and synthesis of Leukotriene A4 hydrolase inhibitors to alleviate idiopathic pulmonary fibrosis and acute lung injury. Eur J Med Chem. 2020;1(203):112614.","journal-title":"Eur J Med Chem"},{"key":"3273_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-137","volume":"7","author":"M Failla","year":"2006","unstructured":"Failla M, Genovese T, Mazzon E, Gili E, Mui\u00e0 C, Sortino M, Crimi N, Caputi AP, Cuzzocrea S, Vancheri C. Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respir Res. 2006;7: 137.","journal-title":"Respir Res"},{"issue":"4","key":"3273_CR32","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.4049\/jimmunol.1600465","volume":"198","author":"J Lv","year":"2017","unstructured":"Lv J, Xiong Y, Li W, Yang W, Zhao L, He R. BLT1 mediates bleomycin-induced lung fibrosis independently of neutrophils and CD4+ T cells. J Immunol. 2017;198(4):1673\u201384.","journal-title":"J Immunol"},{"issue":"11","key":"3273_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.arbres.2019.05.003","volume":"55","author":"JE Davino-Chiovatto","year":"2019","unstructured":"Davino-Chiovatto JE, Oliveira-Junior MC, MacKenzie B, Santos-Dias A, Almeida-Oliveira AR, Aquino-Junior JCJ, Brito AA, Rigonato-Oliveira NC, Damaceno-Rodrigues NR, Oliveira APL, Silva AP, Consolim-Colombo FM, Aimbire F, Castro-Faria-Neto HC, Vieira RP. Montelukast, leukotriene inhibitor, reduces LPS-induced acute lung inflammation and human neutrophil activation. Arch Bronconeumol (Engl Ed). 2019;55(11):573\u201380. https:\/\/doi.org\/10.1016\/j.arbres.2019.05.003. English, Spanish Epub 2019 Jun 27.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"3273_CR34","doi-asserted-by":"publisher","first-page":"175594","DOI":"10.1016\/j.ejphar.2023.175594","volume":"944","author":"Y Wei","year":"2023","unstructured":"Wei Y, Qi M, Liu C, Li L. Astragalus polysaccharide attenuates bleomycin-induced pulmonary fibrosis by inhibiting TLR4\/ NF-\u03baB signaling pathway and regulating gut microbiota. Eur J Pharmacol. 2023;944:175594. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175594. Epub 2023 Feb 17.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"3273_CR35","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.3390\/ijms23105656.PMID:35628464;PMCID:PMC9144898","volume":"23","author":"Y Li","year":"2022","unstructured":"Li Y, Cai W, Jin F, Wang X, Liu W, Li T, Yang X, Liu H, Xu H, Yang F. Thalidomide alleviates pulmonary fibrosis induced by silica in mice by inhibiting ER stress and the TLR4-NF-\u03baB pathway. Int J Mol Sci. 2022;23(10):5656. https:\/\/doi.org\/10.3390\/ijms23105656.PMID:35628464;PMCID:PMC9144898.","journal-title":"Int J Mol Sci"},{"key":"3273_CR36","doi-asserted-by":"publisher","first-page":"101953","DOI":"10.1016\/j.tice.2022.101953","volume":"79","author":"L Wang","year":"2022","unstructured":"Wang L, Shao M, Jiang W, Huang Y. Resveratrol alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and down-regulating TLR4\/NF-\u03baB and TGF-\u03b21\/smad3 signalling pathways in rats. Tissue Cell. 2022;79:101953. https:\/\/doi.org\/10.1016\/j.tice.2022.101953. Epub 2022 Oct 7 PMID: 36228366.","journal-title":"Tissue Cell"},{"key":"3273_CR37","doi-asserted-by":"publisher","first-page":"103316","DOI":"10.1016\/j.resp.2019.103316","volume":"273","author":"AM Kabel","year":"2020","unstructured":"Kabel AM, Estfanous RS, Alrobaian MM. Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis. Respir Physiol Neurobiol. 2020;273:103316. https:\/\/doi.org\/10.1016\/j.resp.2019.103316. Epub 2019 Oct 7.","journal-title":"Respir Physiol Neurobiol"},{"issue":"6","key":"3273_CR38","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/jphp.13077","volume":"71","author":"L Jia","year":"2019","unstructured":"Jia L, Sun P, Gao H, Shen J, Gao Y, Meng C, Fu S, Yao H, Zhang G. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4\/p65 and TGF-\u03b21\/Smad2\/3 pathway. J Pharm Pharmacol. 2019;71(6):1017\u201328.","journal-title":"J Pharm Pharmacol"},{"issue":"2021","key":"3273_CR39","first-page":"8030143","volume":"23","author":"J Wang","year":"2021","unstructured":"Wang J, Wang H, Fang F, Fang C, Wang S, Lu C, Liu N. Danggui buxue tang ameliorates bleomycin-induced pulmonary fibrosis by suppressing the TLR4\/NLRP3 signaling pathway in rats. Evid Based Complement Alternat Med. 2021;23(2021):8030143.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"3273_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1465-9921-10-126","volume":"10","author":"Z He","year":"2009","unstructured":"He Z, Zhu Y, Jiang H. Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study. Respir Res. 2009;10(1):126. https:\/\/doi.org\/10.1186\/1465-9921-10-126.","journal-title":"Respir Res"},{"issue":"4","key":"3273_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrd3203","volume":"9","author":"EJ Hennessy","year":"2010","unstructured":"Hennessy EJ, Parker AE, O\u2019Neill LAJ. Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discovery. 2010;9(4):293\u2013307.","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"3273_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2332\/allergolint.R-07-157","volume":"57","author":"Y Gon","year":"2008","unstructured":"Gon Y. Toll-Like Receptors and Airway Inflammation. Allergol Int. 2008;57(1):33\u20137.","journal-title":"Allergol Int"},{"issue":"12","key":"3273_CR43","doi-asserted-by":"publisher","first-page":"790072","DOI":"10.3389\/fphar.2021.790072","volume":"23","author":"C Zhang","year":"2021","unstructured":"Zhang C, Wang X, Wang C, He C, Ma Q, Li J, Wang W, Xu YT, Wang T. Qingwenzhike prescription alleviates acute lung injury induced by LPS via inhibiting TLR4\/NF-kB pathway and NLRP3 inflammasome activation. Front Pharmacol. 2021;23(12):790072.","journal-title":"Front Pharmacol"},{"issue":"Pt A","key":"3273_CR44","doi-asserted-by":"publisher","first-page":"116918","DOI":"10.1016\/j.jep.2023.116918","volume":"318","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li F, Aga EB, Liang X, He C, Yin L, Xu F, Li H, Tang H, Lv C. \u201cPterocephalodes hookeri-Onosma hookeri\u201d decoction protects against LPS-induced pulmonary inflammation via inhibiting TLR4\/ NF-\u03baB signaling pathway. J Ethnopharmacol. 2024;318(Pt A):116918.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"3273_CR45","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s10753-021-01435-w","volume":"44","author":"J Zhou","year":"2021","unstructured":"Zhou J, Peng Z, Wang J. Trelagliptin alleviates lipopolysaccharide (LPS)-Induced Inflammation and oxidative stress in acute lung injury mice. Inflammation. 2021;44(4):1507\u201317. https:\/\/doi.org\/10.1007\/s10753-021-01435-w. Epub 2021 Mar 10 PMID: 33751359.","journal-title":"Inflammation"},{"issue":"4","key":"3273_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/08958378.2024.2335193","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu Y, Chen H, Wu Y, Ai F, Li W, Peng H, Gui F, Yu B, Chen Z. Sinomenine attenuates bleomycin-induced pulmonary fibrosis, inflammation, and oxidative stress by inhibiting TLR4\/NLRP3\/TGF\u03b2 signaling. Inhal Toxicol. 2024;36(4):217\u201327. https:\/\/doi.org\/10.1080\/08958378.2024.2335193. Epub 2024 May 7 PMID: 38713814.","journal-title":"Inhal Toxicol"},{"key":"3273_CR47","doi-asserted-by":"publisher","first-page":"15813","DOI":"10.3390\/ijms242115813","volume":"24","author":"WC Chen","year":"2023","unstructured":"Chen WC, Yu WK, et al. NLRP3 inflammasome activates endothelial-to-mesenchymal transition via focal adhesion kinase pathway in bleomycin-induced pulmonary fibrosis. Int J Mol Sci. 2023;24:15813.","journal-title":"Int J Mol Sci"}],"updated-by":[{"DOI":"10.1186\/s12890-025-03607-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000}}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03273-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T18:01:04Z","timestamp":1744394464000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03273-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3273"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03273-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12890-025-03607-y","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: \"Following publication of the original article [1], the authors identified an error in Fig. 1A (H&E lung) and Fig. 4. The correct figures are given below.\"","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12890-025-03607-y","URL":"https:\/\/doi.org\/10.1186\/s12890-025-03607-y","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal welfare and experimental protocols adhered to the approved guidelines of the Institutional Animal Care and Use Committee (IACUC) of Nankai University (Permit No. 2024-SYDWLL-000001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"456"}}